Long-Term Risk of Heart Failure in Breast Cancer Patients After Adjuvant Chemotherapy With or Without Trastuzumab-Reference-Cited by-同舟云学术

Long-Term Risk of Heart Failure in Breast Cancer Patients After Adjuvant Chemotherapy With or Without Trastuzumab

Published:2019-03 Issue:3 Volume:7 Page:217-224
ISSN:2213-1779
Container-title:JACC: Heart Failure
language:en
Short-container-title:JACC: Heart Failure

Author:

Banke Ann,Fosbøl Emil L.,Ewertz Marianne,Videbæk Lars,Dahl Jordi S.,Poulsen Mikael Kjær,Cold Søren,Jensen Maj-Britt,Gislason Gunnar H.,Schou Morten,Møller Jacob E.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference30 articles.

1. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012;Ferlay;Int J Cancer,2015

2. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene;Slamon;Science,1987

3. Prognostic importance of c-erbB-2 expression in breast cancer. International (Ludwig) Breast Cancer Study Group;Gusterson;J Clin Oncol,1992

4. The HER-2/neu oncogene in breast cancer: prognostic factor, predictive factor, and target for therapy;Ross;Stem Cells,1998

5. Adjuvant trastuzumab in HER2-positive breast cancer;Slamon;N Engl J Med,2011

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-term risk of heart failure in adult cancer survivors: a systematic review and meta-analysis;Heart;2024-08-22

2. Increasing survivors of anthracycline-related cardiomyopathy with breast cancer in trastuzumab era: thirty-one-year trends in a Japanese Community;Breast Cancer;2024-08-13

3. Trastuzumab-Induced Cardiotoxicity: When and How Much Should We Worry?;JCO Oncology Practice;2024-08

4. Long-term cardiovascular disease risk after anthracycline and trastuzumab treatments in US breast cancer survivors;JNCI: Journal of the National Cancer Institute;2024-05-08

5. Research progress on the improvement of cardiovascular diseases through the autonomic nervous system regulation of the NLRP3 inflammasome pathway;Frontiers in Cardiovascular Medicine;2024-04-08